Survey of the current state of pediatric drug use in Japan (1994-6)

Pediatrics International

Volumn 42, Issue 1, 2000, Pages 109-113

  Onishi, Shoju ^a   Iikura, Yoji ^b   Ushiyama, Makoto ^c   Kitagawa, Teruo ^d   Kobayashi, Yohnosuke ^e   Tsujimoto, Gozoh ^f   Fujimoto, Takeo ^g   Matsuo, Nobutake ^h   Matsudaira, Takamitsu ⁱ   Miura, Hisao ^j   Mino, Makoto ^k   Momma, Kazuo ^l   Yasuda, Tadashi ^m   Ishiki, Gen ⁿ   Matsuda, Ichiro ^o   Itoh, Susumu ^a   Ishii, Yoshiroh ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Ushiyama Children Clinic   (Japan)

^d NIHON UNIVERSITY   (Japan)

^e KANSAI MEDICAL UNIVERSITY   (Japan)

^f NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^g AICHI MEDICAL UNIVERSITY   (Japan)

^h KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ Matsudaira Children Clinic   (Japan)

^j KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k OSAKA MEDICAL COLLEGE   (Japan)

^l TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^m Saitama Social Insurance Hospital   (Japan)

ⁿ OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^o KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

National Health Insurance; Orphan drug; Pediatric drug therapy; Questionnaires; Therapeutic orphan

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; BESTATIN; BRONCHODILATING AGENT; CHARCOAL; COTRIMOXAZOLE; CYPROTERONE ACETATE; DIAZEPAM; DIGITALIS; ERYTHROMYCIN; ETRETINATE; EXPECTORANT AGENT; FLUDROCORTISONE; GANCICLOVIR; HEMOSTATIC AGENT; IMMUNOGLOBULIN; INDOMETACIN; MAZINDOL; METHYLPHENIDATE; ORPHAN DRUG; PENICILLAMINE; PROSTAGLANDIN E1; RECOMBINANT ERYTHROPOIETIN; TACALCITOL; THEOPHYLLINE; TRANILAST; UNINDEXED DRUG; VITAMIN D;

ANEMIA; ARTICLE; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MONITORING; DRUG THERAPY; DRUG USE; FEBRILE CONVULSION; HUMAN; HYPERTROPHIC SCAR; JAPAN; KERATOSIS PALMARIS; NATIONAL HEALTH INSURANCE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; REIMBURSEMENT; STANDARDIZATION;

CHILD; CHILD, PRESCHOOL; DRUG APPROVAL; DRUG MONITORING; DRUG THERAPY; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; PEDIATRICS; QUESTIONNAIRES;

EID: 0034051813     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01073.x     Document Type: Article

References (7)

1. 1 Blumer JL. Developmental pharmacology; Past, present and future. Acta Paediatr. Jpn. 1996; 38: 555-61.
2. 2 Onishi S, Iikura Y, Ushiyama M et al. The state of pediatric therapy in Japan. Jpn. J. Dev. Pharmacol. Ther. 1996; 9: 95-9 (in Japanese).
3. 3 Ogawa Y, Ishizuka Y, Imura S et al. Neonatal off-label drugs -A Japanese perspective. Jpn. J. Dev. Pharmacol. Ther. 1996; 9: 100 (in Japanese).
4. 4 Fujimura M. Pediatric off-label drugs - A Japanese perspective. Jpn. J. Dev. Pharmacol. Ther. 1998; 11: 21-30 (in Japanese).
5. 5 Yaffe S. The Pediatric Pharmacology Research Unit Net Work (PPRU) of the NICHD - A possible solution to the therapeutic orphan. Jpn. J. Dev. Pharmacol. Ther. 1999; 12: 1-2.
6. 6 Onishi S. The way to get rid of the therapeutic orphan. Jpn. J. Dev. Pharmacol. Ther. 1997; 10: 114-20 (in Japanese).
7. 7 Onishi S. The way to get rid of the therapeutic orphan (1997-1998). Jpn. J. Dev. Pharmacol. Ther. 1998; 11: 125-31 (in Japanese).